These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 2914594

  • 1. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B, Hokland M, Justesen J, Hasselbalch H, Ellegaard J, Hokland P.
    Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
    [Abstract] [Full Text] [Related]

  • 2. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD, Cawley JC.
    Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
    [Abstract] [Full Text] [Related]

  • 3. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
    Ferbus D, Billard C, Sigaux F, Thang MN, Falcoff E.
    J Biol Regul Homeost Agents; 1987 Apr; 1(3):147-53. PubMed ID: 2459906
    [Abstract] [Full Text] [Related]

  • 4. Different antitumor mechanisms of interferon-alpha in the treatment of hairy cell leukemia and renal cell cancer.
    Porzsolt F, Digel W, Jacobsen H, Mittnacht S, Kirchner H, Heimpel H.
    Cancer; 1988 Jan 15; 61(2):288-93. PubMed ID: 3334965
    [Abstract] [Full Text] [Related]

  • 5. Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C.
    Appasamy R, Bryant J, Hassanein T, Van Thiel DH, Whiteside TL.
    Clin Immunol Immunopathol; 1994 Dec 15; 73(3):350-7. PubMed ID: 7955564
    [Abstract] [Full Text] [Related]

  • 6. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
    Furuta M, Akashi K, Nakamura Y, Matsumoto K, Yamaguchi H, Takamatsu S, Shimizu T.
    J Interferon Res; 1987 Feb 15; 7(1):111-9. PubMed ID: 3585079
    [Abstract] [Full Text] [Related]

  • 7. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
    Nielsen B, Hokland P, Ellegaard J, Hasselbalch H, Hokland M.
    Leuk Res; 1989 Feb 15; 13(6):451-6. PubMed ID: 2770329
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo effect of interleukin-2 on the 2',5'-oligoadenylate synthetase activity of peripheral mononuclear blood cells.
    Handgretinger R, Bruchelt G, Kimmig A, Lang P, Daurer B, Dopfer R, Treuner J, Niethammer D.
    J Interferon Res; 1990 Feb 15; 10(1):75-82. PubMed ID: 2109781
    [Abstract] [Full Text] [Related]

  • 9. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
    Rosenblum MG, Maxwell BL, Talpaz M, Kelleher PJ, McCredie KB, Gutterman JU.
    Cancer Res; 1986 Sep 15; 46(9):4848-52. PubMed ID: 2942242
    [Abstract] [Full Text] [Related]

  • 10. Modulation of immune functions by long-term treatment with recombinant interferon-alpha 2 in a patient with hairy-cell leukemia.
    Teichmann JV, Sieber G, Ludwig WD, Ruehl H.
    J Interferon Res; 1988 Feb 15; 8(1):15-24. PubMed ID: 3259251
    [Abstract] [Full Text] [Related]

  • 11. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
    Reiter Z, Tomson S, Ozes ON, Taylor MW.
    Blood; 1993 Apr 01; 81(7):1699-708. PubMed ID: 8096405
    [Abstract] [Full Text] [Related]

  • 12. Effect of alpha-interferon on the immune system of patients with hairy cell leukemia.
    Foa R, Fierro MT, Lusso P, Bonferroni M, Raspadori D, Buzzi M, Zinzani PL, Resegotti L, Lauria F.
    Leukemia; 1987 Apr 01; 1(4):377-9. PubMed ID: 3499543
    [Abstract] [Full Text] [Related]

  • 13. Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patients.
    Billard C, Ferbus D, Sigaux F, Castaigne S, Degos L, Flandrin G, Falcoff E.
    Leuk Res; 1988 Apr 01; 12(1):11-8. PubMed ID: 2965776
    [Abstract] [Full Text] [Related]

  • 14. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
    Lahat N, Aghai E, Merchav S, Kinarty A, Sobel E, Froom P.
    Scand J Immunol; 1990 Aug 01; 32(2):205-9. PubMed ID: 2389114
    [Abstract] [Full Text] [Related]

  • 15. Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia.
    Ganeshaguru K, de Mel WC, Sissolak G, Catovsky D, Dearden CE, Mehta AB, Hoffbrand AV.
    Adv Exp Med Biol; 1991 Aug 01; 309A():65-8. PubMed ID: 1789272
    [No Abstract] [Full Text] [Related]

  • 16. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.
    Merritt JA, Borden EC, Ball LA.
    J Interferon Res; 1985 Aug 01; 5(1):191-8. PubMed ID: 3989336
    [Abstract] [Full Text] [Related]

  • 17. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
    Schwarzmeier JD, Schwabe M, Prischl F, Wagner L, Lion T, Micksche M, Köller U.
    Eur J Haematol; 1987 Nov 01; 39(5):418-25. PubMed ID: 3691760
    [Abstract] [Full Text] [Related]

  • 18. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL, Spear GT, Helgeson DO, Lindstrom MJ, Smalley RV, Borden EC.
    J Interferon Res; 1990 Aug 01; 10(4):393-402. PubMed ID: 2121851
    [Abstract] [Full Text] [Related]

  • 19. Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cells.
    Triozzi PL, Avery KA, Grever MR, Kraut EH.
    J Interferon Res; 1990 Oct 01; 10(5):535-40. PubMed ID: 2273300
    [Abstract] [Full Text] [Related]

  • 20. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.
    Preble OT, Rook AH, Steis R, Silverman RH, Krause D, Quinnan GV, Masur H, Jacob J, Longo D, Gelmann EP.
    J Infect Dis; 1985 Sep 01; 152(3):457-65. PubMed ID: 2993441
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.